Clinical Trial Update: Liposomal Amphotericin in Disseminated Leishmaniasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating liposomal amphotericin B for disseminated leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Disseminated Leishmaniasis | Phase 3 | Status: COMPLETED